肝素酶(HPSE)卵白蛋白偶聯(lián)物
OVA Conjugated Heparanase (HPSE)
HPA; HPR1; HPSE1; HSE1; Endo-glucoronidase;
產(chǎn)品包裝(模擬)
產(chǎn)品包裝(模擬)
Mass spectrometry
SDS-PAGE圖
通過ISO 9001、ISO 13485質量體系認證
化學式
用法
Reconstitute in PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復凍融。2-8°C不超過一個月，-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質期內，在適當?shù)臈l件下存儲，損失率低于5%。
相關產(chǎn)品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應用(僅供研究使用，不用于臨床診斷！) |
| RPA711Hu04 | 肝素酶(HPSE)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA711Hu02 | 肝素酶(HPSE)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| APA711Hu04 | 肝素酶(HPSE)活性蛋白 | Cell?culture;?Activity?Assays. |
| APA711Hu01 | 肝素酶(HPSE)活性蛋白 | Cell?culture;?Activity?Assays. |
| EPA711Hu61 | 肝素酶(HPSE)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| APA711Hu61 | 肝素酶(HPSE)活性蛋白 | Cell?culture;?Activity?Assays. |
| RPA711Hu01 | 肝素酶(HPSE)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA711Hu03 | 肝素酶(HPSE)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| CPA711Hu21 | 肝素酶(HPSE)卵白蛋白偶聯(lián)物 | Immunogen; SDS-PAGE; WB. |
| PAA711Hu04 | 肝素酶(HPSE)多克隆抗體 | WB; IHC; ICC; IP. |
| PAA711Hu02 | 肝素酶(HPSE)多克隆抗體 | WB; IHC; ICC/IF |
| PAA711Hu01 | 肝素酶(HPSE)多克隆抗體 | WB; IHC; ICC; IP. |
| PAA711Hu03 | 肝素酶(HPSE)多克隆抗體 | WB; IHC; ICC; IP. |
| FAA711Hu01 | 抗肝素酶(HPSE)多克隆抗體 | Flow cytometry. |
| FAA711Hu03 | 抗肝素酶(HPSE)多克隆抗體 | Flow cytometry. |
| LAA711Hu71 | 肝素酶(HPSE)多克隆抗體(生物素標記) | WB; IHC; ICC. |
| MAA711Hu23 | 肝素酶(HPSE)單克隆抗體 | WB |
| MAA711Hu22 | 肝素酶(HPSE)單克隆抗體 | WB; IHC; ICC; IP. |
| MAA711Hu21 | 肝素酶(HPSE)單克隆抗體 | WB,ICC/IF |
| SEA711Hu | 肝素酶(HPSE)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| HEA711Hu | 肝素酶(HPSE)檢測試劑盒(酶聯(lián)免疫吸附試驗法,高敏型) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMA711Hu | 肝素酶(HPSE)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
| KSA711Hu01 | 肝素酶(HPSE)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻
| 雜志 | 參考文獻 |
| Plos one | PG545, a Heparan Sulfate Mimetic, Reduces Heparanase Expression In Vivo, Blocks Spontaneous Metastases and Enhances Overall Survival in the 4T1 Breast Carcinoma Model[Plosone: Source] |
| Journal of Medical Science | Assessment of heparanase and heparin-binding growth and angiogenesis factors in the uterine cavity ? uid in women with impaired reproduction[Nowinylekarskie:Source] |
| Int J Clin Exp Pathol | Unfractionated heparin attenuates intestinal injury in mouse model of sepsis by inhibiting heparanase[PubMed: 26191183] |
| Tumour Biology | PI-88 inhibits postoperative recurrence of hepatocellular carcinoma via disrupting the surge of heparanase after liver resection[PubMed: 26415733] |
| Journal of Medical Science | Assessment of heparanase and heparin-binding growth and angiogenesis factors in the uterine cavity fluid in women with impaired reproduction[article:84] |
| Renal Failure | Plasma heparanase is associated with blood glucose levels but not urinary microalbumin excretion in type 2 diabetic nephropathy at the early stage [pubmed:28994624] |